Kanamycin activates caspase-1 in NC/Nga mice

Experimental Dermatology

Volumn 20, Issue 8, 2011, Pages 659-663

  Han, Na Ra ^a   Kim, Hyung Min ^a   Jeong, Hyun Ja ^b  

^a Kyung Hee University   (South Korea)

^b Hoseo University   (South Korea)

Author keywords

Caspase 1; Kanamycin; NC Nga mice; Nuclear factor B

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; KANAMYCIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN EXPRESSION; SKIN INFLAMMATION; SPLEEN CELL; UPREGULATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CASPASE 1; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HISTAMINE; I-KAPPA B PROTEINS; IMMUNOGLOBULIN E; INTERLEUKIN-18; INTERLEUKIN-1BETA; KANAMYCIN; MALE; MICE; MICE, INBRED STRAINS; NF-KAPPA B; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960317844     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01291.x     Document Type: Article

References (29)

1. Li C, Lasse S, Lee P et al. Proc Natl Acad Sci USA 2010: 107: 22249-22254.
2. Gustafsson D, Sjöberg O, Foucard T. Allergy 2000: 55: 240-245.
3. Thong B Y. Allergy Asthma Immunol Res 2010: 2: 77-86.
4. Farooqi I S, Hopkin J M. Thorax 1998: 53: 927-932.
5. Ochoa-Repáraz J, Mielcarz D W, Wang Y et al. Mucosal Immunol 2010: 3: 487-495.
6. Choi S E, Jeong M S, Kang M J et al. Exp Dermatol 2010: 19: e37-e43.
7. Watanabe J, Fujiwara R, Sasajima N et al. Biosci Biotechnol Biochem 2010: 74: 358-363.
8. Oyama N, Sudo N, Sogawa H et al. J Allergy Clin Immunol 2001: 107: 153-159.
9. Harada D, Takada C, Nosaka Y et al. Int Immunopharmacol 2009: 9: 55-62.
10. Sugiyama A, Hata S, Suzuki K et al. J Vet Med Sci 2010: 72: 755-763.
11. Gordon J R, Burd P R, Galli S J. Immunol Today 1990: 11: 458-464.
12. Boost K A, Hoegl S, Hofstetter C et al. Intensive Care Med 2007: 33: 863-871.
13. Lamkanfi M, Kanneganti T D, Franchi L et al. J Leukoc Biol 2007: 82: 220-225.
14. Lamkanfi M, Kalai M, Saelens X et al. J Biol Chem 2004: 279: 24785-24793.
15. Beg A A, Finco T S, Nantermet P V et al. Mol Cell Biol 1993: 13: 3301-3310.
16. Baeuerle P A, Baichwal V R. Adv Immunol 1997: 65: 111-137.
17. Karakurum M R, Shreeniwas J, Chen D et al. J Clin Invest 1994: 93: 1564-1570.
18. Orfali R L, Sato M N, Takaoka R et al. Exp Dermatol 2009: 18: 628-633.
19. Moon P D, Na J J, Jeong H J et al. J Pharm Pharm Sci 2005: 8: 94-101.
20. Shore P A, Burkhalter A, Cohn V H Jr. J Pharmacol Exp Ther 1959: 127: 182-186.
21. Jeong H J, Lee S A, Moon P D et al. Clin Exp Allergy 2006: 36: 785-794.
22. Jeong H J, Hong S H, Lee D J et al. Cell Signal 2002: 14: 633-639.
23. Sonnenburg J L, Angenent L T, Gordon J I. Nat Immunol 2004: 5: 569-573.
24. Kelly D, Conway S, Aminov R. Trends Immunol 2005: 26: 326-333.
25. Lin R Y, Schwartz L B, Curry A et al. J Allergy Clin Immunol 2000: 106: 65-71.
26. Ok I S, Kim S H, Kim B K et al. Mediators Inflamm 2009: 2009: 413270.
27. Murakami T, Yamanaka K, Tokime K et al. Br J Dermatol 2006: 155: 27-32.
28. Suschek C V, Bonmann E, Kapsokefalou A et al. Mol Pharmacol 2002: 62: 936-946.
29. Cheneval D, Ramage P, Kastelic T et al. J Biol Chem 1998: 273: 17846-17851.